JP2022548312A5 - - Google Patents

Info

Publication number
JP2022548312A5
JP2022548312A5 JP2022518190A JP2022518190A JP2022548312A5 JP 2022548312 A5 JP2022548312 A5 JP 2022548312A5 JP 2022518190 A JP2022518190 A JP 2022518190A JP 2022518190 A JP2022518190 A JP 2022518190A JP 2022548312 A5 JP2022548312 A5 JP 2022548312A5
Authority
JP
Japan
Prior art keywords
glycero
alkyl
compound according
phosphocholine
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518190A
Other languages
English (en)
Japanese (ja)
Other versions
JP7642620B2 (ja
JP2022548312A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051629 external-priority patent/WO2021055849A1/en
Publication of JP2022548312A publication Critical patent/JP2022548312A/ja
Publication of JP2022548312A5 publication Critical patent/JP2022548312A5/ja
Application granted granted Critical
Publication of JP7642620B2 publication Critical patent/JP7642620B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518190A 2019-09-19 2020-09-18 治療剤の細胞内送達のための頭部基脂質化合物及び組成物 Active JP7642620B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962902928P 2019-09-19 2019-09-19
US62/902,928 2019-09-19
PCT/US2020/051629 WO2021055849A1 (en) 2019-09-19 2020-09-18 Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents

Publications (3)

Publication Number Publication Date
JP2022548312A JP2022548312A (ja) 2022-11-17
JP2022548312A5 true JP2022548312A5 (enExample) 2023-09-26
JP7642620B2 JP7642620B2 (ja) 2025-03-10

Family

ID=72840615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518190A Active JP7642620B2 (ja) 2019-09-19 2020-09-18 治療剤の細胞内送達のための頭部基脂質化合物及び組成物

Country Status (11)

Country Link
US (1) US20230000773A1 (enExample)
EP (1) EP4031527A1 (enExample)
JP (1) JP7642620B2 (enExample)
KR (1) KR20220103923A (enExample)
CN (1) CN114746398A (enExample)
AU (1) AU2020351225A1 (enExample)
BR (1) BR112022004771A2 (enExample)
CA (1) CA3154720A1 (enExample)
IL (1) IL291375A (enExample)
MX (1) MX2022003402A (enExample)
WO (1) WO2021055849A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6948313B6 (ja) 2015-09-17 2022-01-14 モデルナティエックス インコーポレイテッド 治療剤の細胞内送達のための化合物および組成物
LT3394030T (lt) 2015-12-22 2022-04-11 Modernatx, Inc. Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
WO2018170322A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Crystal forms of amino lipids
EP4186888B1 (en) 2017-03-15 2025-11-26 ModernaTX, Inc. Compound and compositions for intracellular delivery of therapeutic agents
CA3055653A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Lipid nanoparticle formulation
WO2018232120A1 (en) 2017-06-14 2018-12-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
CN112399860B (zh) 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
WO2020061367A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
WO2020061295A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. High-purity peg lipids and uses thereof
KR20210133218A (ko) 2019-01-31 2021-11-05 모더나티엑스, 인크. 볼텍스 믹서 및 연계된 방법, 시스템 및 이의 장치
CN113874502A (zh) 2019-03-11 2021-12-31 摩登纳特斯有限公司 补料分批体外转录方法
BR112021023411A2 (pt) 2019-05-22 2022-02-01 Massachusetts Inst Technology Composições e métodos de rna circular
AU2020350759A1 (en) 2019-09-19 2022-03-31 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
CA3155015A1 (en) 2019-09-19 2021-03-25 Modernatx, Inc. Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
CN121422256A (zh) * 2019-12-04 2026-01-30 奥纳治疗公司 环状rna组合物和方法
WO2022115645A1 (en) 2020-11-25 2022-06-02 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids, and related methods of use
US20240226026A1 (en) * 2021-03-24 2024-07-11 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
AU2022264775A1 (en) * 2021-04-26 2023-11-09 Ohio State Innovation Foundation Lipid nanomaterials and uses thereof
US20220363937A1 (en) 2021-05-14 2022-11-17 Armstrong World Industries, Inc. Stabilization of antimicrobial coatings
CN114149337B (zh) * 2021-07-07 2022-04-29 天津键凯科技有限公司 一种用于核酸递送的新型可电离脂质及其lnp组合物
WO2023018773A1 (en) * 2021-08-11 2023-02-16 Modernatx, Inc. Lipid nanoparticle formulations and methods of synthesis thereof
CN113461577B (zh) * 2021-09-01 2021-12-14 中山大学附属第七医院(深圳) 一种氨基脂质及其应用
US20240398940A1 (en) 2021-09-03 2024-12-05 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
EP4422698A1 (en) 2021-10-29 2024-09-04 CureVac SE Improved circular rna for expressing therapeutic proteins
AR127892A1 (es) 2021-12-10 2024-03-06 Modernatx Inc Compuestos y composiciones para la administración de agentes terapéuticos
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
EP4475882A1 (en) 2022-02-09 2024-12-18 ModernaTX, Inc. Mucosal administration methods and formulations
CN116813493B (zh) * 2022-03-21 2026-04-28 苏州科锐迈德生物医药科技有限公司 一种脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
KR102560772B1 (ko) * 2022-03-21 2023-07-28 주식회사 메디치바이오 신규한 이온화지질 및 이를 이용한 지질나노입자 조성물
EP4509544A4 (en) * 2022-04-12 2025-07-02 Xiamen Sinopeg Biotech Co Ltd NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND ITS APPLICATION
CA3256897A1 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for the administration of nucleic acids and their methods of use
US20250345407A1 (en) 2022-05-25 2025-11-13 CureVac SE Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide
US12297285B2 (en) 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA
CN115232128B (zh) * 2022-08-15 2024-03-29 中国科学技术大学 一种咪唑并吡啶基脂质化合物及其制备方法与应用
CN115557875B (zh) * 2022-08-19 2025-01-03 上海耐澄生物科技有限公司 一种脂质化合物及脂质纳米颗粒
EP4608442A1 (en) 2022-10-28 2025-09-03 GlaxoSmithKline Biologicals S.A. Nucleic acid based vaccine
EP4627085A1 (en) * 2022-11-29 2025-10-08 The Trustees of Indiana University Long non-coding rna lipter preserves lipid metabolism of the human heart
WO2024123978A1 (en) 2022-12-08 2024-06-13 Modernatx, Inc. Ionizable lipids with malonate tails
WO2024140835A1 (zh) * 2022-12-28 2024-07-04 仁景(苏州)生物科技有限公司 脂质化合物和脂质纳米颗粒组合物
CN115677518B (zh) * 2023-01-05 2023-04-14 北京悦康科创医药科技股份有限公司 用于递送核酸的可电离阳离子脂质化合物和组合物及用途
CN118356505A (zh) * 2023-01-10 2024-07-19 复旦大学 含末端羟基的peg化纳米载体在制备规避人体预存抗peg抗体的药物制剂中的用途
CN121263425A (zh) * 2023-02-13 2026-01-02 旗舰创业创新第七有限责任公司 含可裂解接头的可电离脂质和用于治疗性组合物的脂质载体
WO2024184500A1 (en) 2023-03-08 2024-09-12 CureVac SE Novel lipid nanoparticle formulations for delivery of nucleic acids
WO2024197310A1 (en) 2023-03-23 2024-09-26 Modernatx, Inc. Peg targeting compounds for delivery of therapeutics
EP4683665A1 (en) 2023-03-23 2026-01-28 ModernaTX, Inc. Peg targeting compounds for delivery of therapeutics
EP4683666A1 (en) 2023-03-23 2026-01-28 ModernaTX, Inc. Peg targeting compounds for delivery of therapeutics
EP4707289A1 (en) 2023-04-29 2026-03-11 Cansino (Shanghai) Biological Research Co., Ltd. Steroid-cationic lipid compound and use thereof
CN118845700A (zh) 2023-04-29 2024-10-29 康希诺(上海)生物研发有限公司 一种用于递送核酸药物的脂质纳米颗粒及其制备方法和用途
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
CN116675624B (zh) * 2023-05-29 2025-02-14 上海耐澄生物科技有限公司 一种脂质化合物及脂质纳米颗粒
KR20240172540A (ko) * 2023-06-01 2024-12-10 주식회사 기프티드엠에스 세포 투과가 가능한 펩타이드-핵산 올리고머를 유효성분으로 포함하는 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물
WO2024259373A1 (en) 2023-06-14 2024-12-19 Modernatx, Inc. Compounds and compositions for delivery of therapeutic agents
WO2025100737A1 (ko) * 2023-11-06 2025-05-15 주식회사 메디치바이오 신규한 이온화 지질 및 이를 포함하는 지질 나노입자 조성물
WO2025146125A1 (zh) * 2024-01-05 2025-07-10 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
CN117942406B (zh) * 2024-01-19 2025-07-11 晟迪生物医药(苏州)有限公司 预制载体在制备用于免疫细胞和干细胞的体外基因递送的产品中的应用
CN118290339B (zh) * 2024-03-20 2025-03-07 北京剂泰医药科技有限公司 可电离脂质化合物及其应用
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026035680A1 (en) 2024-08-06 2026-02-12 Kernal Biologics, Inc. Compositions and methods for delivery of agents
US20260098014A1 (en) * 2024-10-08 2026-04-09 Flagship Pioneering Innovations Vii, Llc Ionizable lipidoid compositions and therapeutic uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2817287B1 (en) * 2012-02-24 2018-10-03 Arbutus Biopharma Corporation Trialkyl cationic lipids and methods of use thereof
JP6620093B2 (ja) * 2013-07-23 2019-12-11 アービュートゥス バイオファーマ コーポレイションArbutus Biopharma Corporation メッセンジャーrnaを送達するための組成物及び方法
JP6948313B6 (ja) * 2015-09-17 2022-01-14 モデルナティエックス インコーポレイテッド 治療剤の細胞内送達のための化合物および組成物
EP3350333B2 (en) 2015-09-17 2025-08-06 ModernaTX, Inc. Polynucleotides containing a stabilizing tail region
EP3359670B2 (en) 2015-10-05 2024-02-14 ModernaTX, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
EP4186888B1 (en) * 2017-03-15 2025-11-26 ModernaTX, Inc. Compound and compositions for intracellular delivery of therapeutic agents
MA51523A (fr) * 2018-01-05 2020-11-11 Modernatx Inc Polynucléotides codant pour des anticorps anti-virus du chikungunya
US20190314291A1 (en) * 2018-01-30 2019-10-17 Modernatx, Inc. Compositions and methods for delivery of agents to immune cells
WO2020061367A1 (en) * 2018-09-19 2020-03-26 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents

Similar Documents

Publication Publication Date Title
JP2022548312A5 (enExample)
JP2022549253A5 (enExample)
JP2022548304A5 (enExample)
JP2025502627A5 (enExample)
JP6442551B2 (ja) 薬物送達用の脂質ナノ粒子の生成方法
JP6592458B2 (ja) カチオン性脂質
JP5977394B2 (ja) 脂質に封入された干渉rna
JP2022501360A5 (enExample)
JP2020532528A5 (enExample)
JP2020514366A5 (enExample)
JP6389477B2 (ja) カチオン性脂質
JP7423518B2 (ja) 生物学的活性分子を送達するための融合性化合物
WO2011056682A1 (en) Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
US20190380963A1 (en) Liposome preparation having high-content cationic lipid compound and use thereof
AU2013380825B2 (en) Lipidosome preparation, preparation method and application thereof
IL319522A (en) Ionizable lipid materials, nanoparticles containing them, and their uses
CN115417779B (zh) 可离子化的阳离子脂c6-a1及由其组成的纳米脂质体颗粒
CN115417780B (zh) 可离子化的阳离子脂c5-a2及由其组成的纳米脂质体颗粒
JP5914418B2 (ja) 脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
CN119365189A (zh) 一种高转染效率的阳离子脂质纳米粒及其制备方法
WO2025256540A1 (en) Compositions and method for targeted gene delivery
KR20260059895A (ko) 신규한 이온화 스테롤 유도체 및 이를 포함하는 지질 나노입자 조성물
CN120774809A (zh) 一种肺靶向脂质纳米颗粒的构建及应用
CN119019272A (zh) 可电离脂质、包含其的组合物及其用途
CN120040464A (zh) 一种新型可电离脂质分子的制备和应用